Do You Still Have A Reason To Buy Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) After A 9.80% Jump In The Last Week?
During the last session, Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)’s traded shares were 2.91 million, with the beta value of the company hitting 0.62. At the end